Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-01-01 @ 4:45 AM
Study NCT ID:
NCT04276233
Status:
COMPLETED
Last Update Posted:
2024-12-10
First Post:
2020-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-17
First Submit QC Date:
None
Study First Post Date:
2020-02-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-27
Results First Submit QC Date:
None
Results First Post Date:
2024-12-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-27
Last Update Post Date:
2024-12-10
Last Update Post Date Type:
ACTUAL